Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
This work investigated the profile of inflammation biomarkers in patients with chronic hepatitis C and its association with liver fibrosis, hepatic necroinflammatory activity, viral genotypes and cryoglobulinemia.
Subjects and methods
Seventy-eight untreated patients were studied. Biomarker levels were determined by immunoassays, cryoglobulinemia by cryoprecipitation and liver histopathology investigated using METAVIR scores.
Decreased levels of α1-acid glycoprotein (AGP), C3 and haptoglobin (Hp) were observed in the patients (P < 0.0001). Increased α1-antitrypsin (P < 0.01) and ferritin (P < 0.0001) levels were found in this group, but C-reactive protein (CRP) and C4 levels were unaltered. Alanine aminotransferase inversely correlated with Hp (P < 0.01) and AGP (P = 0.01), whereas it was directly correlated with ferritin (P < 0.05) and AGP (P < 0.0001). The levels of CRP, C3 and C4 were lower in the patients with hepatic necroinflammatory activity (P < 0.05). Patients with advanced fibrosis had low levels of Hp and AGP (P < 0.05 and P < 0.01, respectively). Neither infection with different viral genotypes nor cryoglobulinemia caused an alteration in biomarker levels.
Chronic hepatitis C virus infection alters the levels of some biomarkers, which are mainly observed in patients with liver fibrosis and hepatic necroinflammatory activity.
- Tellinghuisen T, Rice C. Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol. 2002;5:419–27. CrossRef
- Chen S, Morgan T. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:47–52. CrossRef
- Dustin L, Rice C. Flying under the radar: the immunobiology of hepatitis C. Ann Rev Immunol. 2007;25:71–99. CrossRef
- Atta AM, Estevam P, Paraná R, Pereira CM, Leite BC, Sousa-Atta ML. Antiphospholipid antibodies in Brazilian hepatitis C virus carriers. Braz J Med Biol Res. 2008;41:489–92. CrossRef
- Atta AM, Oliveira IS, Sousa GM, Paraná R, Sousa Atta ML. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies. Microb Pathogen. 2010;48:53–6. CrossRef
- Gramenzi A, Andreone P, Loggi E, Foschi F, Cursaro C, Margotti M, et al. Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. J Viral Hepat. 2005;12:525–30. CrossRef
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–54. CrossRef
- Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology. 1996;24:289–93. CrossRef
- Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat. 2002;9:128–33. CrossRef
- Rosenthal-Allieri M, Peritore M-L, Tran A, Halfon P, Benzaken S, Bernard A. Analytical variability of the Fibrotest proteins. Clin Biochem. 2005;38:473–8. CrossRef
- Bacq Y, Schillio Y, Brechot J, De Muret A, Dubois F, Metman E. Decrease of haptoglobin serum level in patients with chronic viral hepatitis C. Gastroenterol Clin Biol. 1993;17:364–9.
- Kasvosve I, Gomo Z, Gangaidzo I, Mvundura E, Saungweme T, Moyo V, et al. Reference range of serum haptoglobin is phenotype-dependent in blacks. Clin Chim Acta. 2000;296:163–70. CrossRef
- Hochepied T, Berger FG, Baumann H, Libert C. Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev. 2003;14:25–34. CrossRef
- Fournier T, Medjoubi-N N, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta. 2000;1482:157–71. CrossRef
- Anderson N, Pollacchi A, Hayes P, Therapondos G, Newsome P, Boyter A, Smith K. A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases. Biomed Chromatogr. 2002;16:365–72. CrossRef
- Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W. High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin and chronic liver disease. Ann Intern Med. 1992;117:641–5.
- Elzouki AN, Verbaan H, Lindgren S, Widell A, Carlson J, Eriksson S. Serine protease inhibitors in patients with chronic viral hepatitis. J Hepatol. 1997;27:42–8. CrossRef
- Lin T, Liao L, Lin S, Lin C, Chang T. Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C. World J Gastroenterol. 2006;12:4897–901.
- Fabris C, Toniutto P, Scott C, Falleti E, Avellini C, Del Forno M, et al. Serum iron indices as a measure of iron deposits in chronic hepatitis C. Clin Chim Acta. 2001;304:49–55. CrossRef
- Metwally M, Zein C, Zein N. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol. 2004;99:286–91. CrossRef
- Guyader D, Thirouard A, Erdtmann L, Rakba N, Jacquelinet S, Danielou H, et al. Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C. J Hepatol. 2007;46:587–95. CrossRef
- Shan Y, Lambrecht RW, Bonkovsky HL. Association of hepatitis C virus infection with serum iron status: analysis of data from the third national health and nutrition examination survey. Clin Infect Dis. 2005;40:834–41. CrossRef
- Sousa GM, Oliveira RC, Pereira MM, Paraná R, Sousa-Atta MLB, Atta AM. Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin. Autoimmun Rev. 2011;10:210–3. CrossRef
- Distante S, Bjoro K, Hellum K, Myrvang B, Berg J, Skaug K, et al. Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection. Liver. 2002;22:269–75. CrossRef
- Kalabay L, Nemesánszky E, Csepregi A, Pusztay M, Dávid K, Horváth G, et al. Paradoxical alteration of acute-phase protein levels in patients with chronic hepatitis C treated with IFN-alpha2b. Int Immunol. 2004;16:51–4. CrossRef
- Nascimento M, Bruchfeld A, Suliman M, Hayashi S, Pecoits-Filho R, Manfro R, et al. Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients. Braz J Med Biol Res. 2005;38:783–8. CrossRef
- Kessel A, Elias G, Pavlotzky E, Zuckerman E, Rosner I, Toubi E. Anti-C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity. Hum Immunol. 2007;68:844–8. CrossRef
- Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB. Hepatitis C virus proteins inhibit C3 complement production. J Virol. 2012;86:2221–8. CrossRef
- Dumestre-Perard C, Ponard D, Drouet C, Leroy V, Zarski J-P, Dutertre N, Colomb MG. Complement C4 monitoring in the follow-up of chronic hepatitis C treatment. Clin Exp Immunol. 2002;127:131–6. CrossRef
- Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis. 2005;5:227–36. CrossRef
- Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia
Volume 61, Issue 10 , pp 1101-1106
- Cover Date
- Print ISSN
- Online ISSN
- SP Birkhäuser Verlag Basel
- Additional Links
- Hepatitis C
- Inflammation biomarkers
- Liver histopathology
- Viral genotype
- Industry Sectors
- Author Affiliations
- 1. Departamento de Análises Clínicas e Toxicológicas, Universidade Federal da Bahia, Salvador, Brazil
- 2. Programa de Pós-Graduação em Farmácia, Universidade Federal da Bahia, Salvador, Brazil
- 3. Programa de Pós-Graduação em Imunologia, Universidade Federal da Bahia, Salvador, Brazil
- 4. Serviço de Gastroenterologia do Complexo Hospitalar Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil